Gilead Sciences (GILD) Acquisitions (2011 - 2026)

Gilead Sciences (GILD) has 10 years of Acquisitions data on file, last reported at $109.0 million in Q1 2026.

• For the quarter ending Q1 2026, Acquisitions fell 60.07% year-over-year to $109.0 million; the trailing twelve-month figure through Mar 2026 stood at $906.0 million (down 15.33% YoY), and the FY2025 full-year result was $1.1 billion, down 77.89% from the prior year.
• Acquisitions for Q1 2026 stood at $109.0 million, down from $609.0 million in the prior quarter.
• Across five years, Acquisitions topped out at $4.0 billion in Q1 2024 and bottomed at $21.0 million in Q2 2025.
• The 5-year median for Acquisitions is $273.0 million (2025), against an average of $527.5 million.
• Peak annual rise in Acquisitions reached 712.0% in 2025, while the deepest fall reached 93.25% in 2025.
• A 5-year view of Acquisitions shows it stood at $218.0 million in 2022, then advanced by 27.98% to $279.0 million in 2023, then plunged by 73.12% to $75.0 million in 2024, then soared by 712.0% to $609.0 million in 2025, then plunged by 82.1% to $109.0 million in 2026.
• The last three Acquisitions figures came in at $109.0 million (Q1 2026), $609.0 million (Q4 2025), and $167.0 million (Q3 2025), per Business Quant data.

Peer Comparison